Anti-CC85A/ CCDC85A functional antibody

Anti-CC85A/ CCDC85A functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CCDC85A/CCDC85A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1409-Ab-1/ GM-Tg-hg-SE1409-Ab-2Anti-Human CCDC85A monoclonal antibodyHuman
GM-Tg-rg-SE1409-Ab-1/ GM-Tg-rg-SE1409-Ab-2Anti-Rat CCDC85A monoclonal antibodyRat
GM-Tg-mg-SE1409-Ab-1/ GM-Tg-mg-SE1409-Ab-2Anti-Mouse CCDC85A monoclonal antibodyMouse
GM-Tg-cynog-SE1409-Ab-1/ GM-Tg-cynog-SE1409-Ab-2Anti-Cynomolgus/ Rhesus macaque CCDC85A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1409-Ab-1/ GM-Tg-felg-SE1409-Ab-2Anti-Feline CCDC85A monoclonal antibodyFeline
GM-Tg-cang-SE1409-Ab-1/ GM-Tg-cang-SE1409-Ab-2Anti-Canine CCDC85A monoclonal antibodyCanine
GM-Tg-bovg-SE1409-Ab-1/ GM-Tg-bovg-SE1409-Ab-2Anti-Bovine CCDC85A monoclonal antibodyBovine
GM-Tg-equg-SE1409-Ab-1/ GM-Tg-equg-SE1409-Ab-2Anti-Equine CCDC85A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1409-Ab-1/ GM-Tg-hg-SE1409-Ab-2; GM-Tg-rg-SE1409-Ab-1/ GM-Tg-rg-SE1409-Ab-2;
GM-Tg-mg-SE1409-Ab-1/ GM-Tg-mg-SE1409-Ab-2; GM-Tg-cynog-SE1409-Ab-1/ GM-Tg-cynog-SE1409-Ab-2;
GM-Tg-felg-SE1409-Ab-1/ GM-Tg-felg-SE1409-Ab-2; GM-Tg-cang-SE1409-Ab-1/ GM-Tg-cang-SE1409-Ab-2;
GM-Tg-bovg-SE1409-Ab-1/ GM-Tg-bovg-SE1409-Ab-2; GM-Tg-equg-SE1409-Ab-1/ GM-Tg-equg-SE1409-Ab-2
Products NameAnti-CCDC85A monoclonal antibody
Formatmab
Target NameCCDC85A
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CCDC85A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1409-Ag-1Recombinant multi-species CC85A/ CCDC85A protein


    Target information

    Target IDGM-SE1409
    Target NameCCDC85A
    Gene ID114800,216613,289855,717376,481377,101094840,525800,100052299
    Gene Symbol and SynonymsCCDC85A,RGD1311700
    Uniprot AccessionQ96PX6
    Uniprot Entry NameCC85A_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000055813
    Target ClassificationN/A

    The target: CCDC85A, gene name: CCDC85A, also named as . Located in adherens junction. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.